- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Are MRIs Overused?
It’s a question posed in a The New York Times article last week that explored MRIs in sports medicine.
Are MRIs overused? It’s a question posed in a The New York Times article last week that explored MRIs in sports medicine.
“If you want an excuse to operate on a pitcher’s throwing shoulder, just get an MRI,” James Andrews, MD, a sports medicine orthopedist in Gulf Breeze, Fla., told the Times. He suspected that MRIs were overused, so he scanned 31 healthy athletes and found 90 percent had abnormal cartilage and 87 percent had abnormal rotator cuff tendons. Andrews and his sports medicine colleagues say that indeed the scan is overused and often not the oppropriate scan in sports injuries.
MRIs are sensitive but not very specific, as one doctor explained, so they can lead to misdiagnoses and unnecessary treatments in sports medicine. Yet, sports medicine patients often demand an MRI and physicians are reluctant not to order one, according to the Times.
Of course, MRIs can be extremely helpful in sports medicine, but must be considered alongside history and an exam to avoid overuse, according to one source.
What do you think? Is there a fine line between appropriate use and overuse? Are there other areas where MRIs are often ordered but might not be the right scan?
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
